Professor of Medicine, University VA School of Medicine
Hematology
Dr. Geoffrey R. Weiss, MD
|
|
Give Review
Dr. Geoffrey R. Weiss is an expert in the field of Hematology. He attended Saint Louis University School of Medicine. Saint Louis University School of Medicine is ranked 67 in research and 57 in primary care medicine He has 4 awards "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer" and "Super Doctor". Geoffrey Weiss is also published. He has 25 publications published. The lastest publication: "Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: A Phase II trial (CTEP 7190/ Mel47).' He is registered with Medicare.
Publications
- Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: A Phase II trial (CTEP 7190/ Mel47).
- A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer.
- Surgical Management of the Patient with Metastatic Melanoma to the Heart.
- Doege-Potter syndrome presenting with hypoinsulinemic hypoglycemia in a patient with a malignant extrapleural solitary fibrous tumor: a case report.
- Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.
- Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
- Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study.
- Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients Wi...
- Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
- Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Onc...
- Locally advanced prostate cancer treated with concomitant radiation and 5-fluorouracil: Southwest Oncology Group Study 9024.
- A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest ...
- Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levami...
- Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study.
- Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vi...
- A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasms.
- Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncolo...
- Current issues in the management of advanced squamous cell carcinoma of the penis.
- Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial.
- Phase 1 study of the intravesical administration of recombinant human interleukin-12 in patients with recurrent superficial transitional cell carcinoma of the bladder.
- Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and per...
- A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with...
- Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study.
- Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the South...
Schools
Saint Louis University School Of Medicine
Temple University Hospital
Dana Farber Cancer Institute
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Super Doctor
Education
-
Temple University Hospital -
Saint Louis University School of Medicine
Hospital
-
University of Virginia Medical Center
Drug Facts
| NPI NUMBER | 1831268473 | |
| NPPES Provider LastName | WEISS | |
| NPPES Provider FirstName | GEOFFREY | |
| NPPES Provider ZIPCode | 229080001 | |
| NPPES Provider State | VA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 496.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 104.0 | |
| Percent Opioid Claims | 20.97 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831268473 |
| Last Name Of The Provider | WEISS |
| First Name Of The Provider | GEOFFREY |
| View All |
Similar Doctors
|
Dr. Michael G. Douvas, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Emanuel E. Cirenza, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas P. Loughran, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Maya Ghaemmaghami, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas J. Harris, MD |
|
|
Dr. Leonid Volodin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathan R. Shumaker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew M. Romano, MD |
|
|
Dr. Andrew C. Shaw, MD |
|
|
Aarti Ailawadi, PA |
|
Sherry B. Clark, NP
This Doctor is OpenDoctor Recommended.
|